189 results on '"Hammock, Bruce D"'
Search Results
2. Alzheimer’s disease genetics and real‐world patient data fuel target and drug discovery in European and African American ancestries
3. Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity
4. A New Family of Subnanomolar inhibitors of Soluble Epoxide Hydrolase
5. Dual COX‐2/sEH Inhibition and Immune Checkpoint Blockade Regress Bladder Cancer Tumors in Mice
6. Soluble Epoxide Hydrolase Inhibitors: Design, Synthesis, in vitro Profiling and in vivo Evaluation in Murine Models of Pain
7. Immunonutritional Targeting of Cancer via Eicosanoids
8. Clinical and Preclinical Evidence for Roles of Soluble Epoxide Hydrolase in Osteoarthritis Knee Pain
9. Efficacy of soluble epoxide hydrolase inhibition in a rat model of Alzheimer’s disease
10. Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats
11. Development of a direct competitive enzyme‐linked immunosorbent assay for quantitation of sodium saccharin residue in food
12. Dually targeting human soluble epoxide hydrolase and P38 kinase to prevent neuroinflammation for the treatment of Alzheimer’s disease
13. Target‐Mediated Drug Disposition—A Class Effect of Soluble Epoxide Hydrolase Inhibitors
14. Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine
15. Soluble epoxide hydrolase inhibition improves cognitive function and parenchymal artery dilation in a hypertensive model of chronic cerebral hypoperfusion
16. Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model
17. Chemoprevention of Aflatoxin B1‐Induced Cytokine Storm and Tumor Dormancy Escape via Dual COX‐2/sEH Inhibition
18. Pharmacological inhibition of soluble epoxide hydrolase alleviates chronic neuropathic pain induced anhedonia symptoms: differential role of AhR and TSPO signaling
19. A DUAL COX‐2/sEH INHIBITOR TREATED KIDNEY INJURY IN A DRUG‐INDUCED GLOMERULAR DISEASE MODEL
20. Development of Potent Inhibitors of the Human Microsomal Epoxide Hydrolase
21. Pharmacokinetics of a potent soluble epoxide hydrolase inhibitor in three formulations
22. DUAL ACTING COX‐2 AND SOLUBLE EPOXIDE HYDROLASE INHIBITOR ATTENUATES GLOMERULAR INJURY IN FOCAL SEGMENTAL GLOMERULAR SCLEROSIS
23. Investigating the Effects of Epoxy Fatty Acids against LPS and Pesticide Induced Toxicity
24. Maternal Glyphosate Exposure Causes Autism‐like Behaviors in Offspring through Increased Expression of Soluble Epoxide Hydrolase
25. Inactivation of Cys 674 in SERCA2 increases BP by inducing endoplasmic reticulum stress and soluble epoxide hydrolase
26. COX‐2/sEH dual inhibitor PTUPB alleviates bleomycin‐induced pulmonary fibrosis in mice via inhibiting senescence
27. Acute Hypercapnia/Ischemia Alters the Esterification of Arachidonic Acid and Docosahexaenoic Acid Epoxide Metabolites in Rat Brain Neutral Lipids
28. Improving the sensitivity of traditional Western blotting via Streptavidin containing Poly‐horseradish peroxidase (PolyHRP)
29. Development of an immunoassay for the detection of carbaryl in cereals based on a camelid variable heavy‐chain antibody domain
30. A Novel Dual Soluble Epoxide Hydrolase Inhibitor/Cyclooxygenase‐2 Inhibitor Treats Type 2 Diabetic Complications in Obese ZSF1 Rats
31. Synthesis of a New Family of Soluble Epoxide Hydrolase Inhibitors, in vitro Profiling and in vivo Evaluation in a Murine Model of Acute Pancreatitis
32. Cover Feature: Impedance Detection of 3-Phenoxybenzoic Acid with a Noncompetitive Two-site Phage Anti-immunocomplex Assay (Electroanalysis 11/2018)
33. Impedance Detection of 3-Phenoxybenzoic Acid with a Noncompetitive Two-site Phage Anti-immunocomplex Assay
34. A Key Role of Soluble Epoxide Hydrolase in the Pathogenesis of Parkinson's Disease
35. Can Inhibition of Soluble Epoxide Hydrolase Ameliorate Increased Susceptibility to DSS Induced Colitis in Soybean Oil Fed Mice?
36. Inhibitor of Soluble Epoxide Hydrolase Attenuates Decline in Learning and Memory of Diabetic Rats
37. In Vitro and In Vivo Metabolism of Soluble Epoxide Hydrolase Inhibitor 1‐ Trifluoromethoxyphenyl‐3‐(1‐propionylpiperidin‐4‐yl) Urea (TPPU)
38. Dual Inhibitors of Cyclooxygenase‐2 and Soluble Epoxide Hydrolase: Studies of Binding Modes at the Active Sites and Time‐dependency of Inhibition, and Development of Water‐soluble Prodrugs
39. Estrogen‐dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation
40. Inhibition of Soluble Epoxide Hydrolase Attenuates Food Allergen‐induced Eosinophil Recruitment and Gastrointestinal Inflammation
41. Soluble Epoxide Hydrolase/Phosphodiesterase Dual Inhibitor is Efficacious Against Inflammatory Pain
42. Identification of Potent Soluble Epoxide Hydrolase Inhibitors for Veterinarian Usage
43. Inhibition of soluble epoxide hydrolase attenuates the kidney injury caused by ischemia/reperfusion in a murine model of acute kidney injury involved in GSK‐3β phosphorylation
44. Lipidomic Profiling Reveals Soluble Epoxide Hydrolase As a Therapeutic Target of Obesity‐induced Colonic Inflammation
45. Development of a comprehensive profiling method for regulatory lipid mediators using UPLC‐MS/MS
46. A Dual‐Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Alleviating Tau Hyperphosphorylation and Amyloid Neurotoxicity for Potential Treatment of Neuroinflammation in Alzheimer's Disease
47. Development of Tetramethylenedisulfotetramine (TETS) Hapten Library: Synthesis, Electrophysiological Studies, and Immune Response in Rabbits.
48. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury
49. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats
50. Lipidomic Profiling Identifies Cytochrome P450 as A Therapeutic Target for Colitis‐Associated Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.